Factors affecting oral health status in Schizophrenia patients

Main Article Content

สาธกา ธาตรีนรานนท์

Abstract

The purposes of this study were to assess oral health status of schizophrenia patients and to evaluate factors that affect oral health status. Participants consisted of 185 schizophrenia in-patients  at Somdet Chaopraya Institute of Psychiatry.  During March- April 2016, specific questionnaire, medical and dental treatment form and oral health examination form were used to collect 3 datasets which the factors were age, sex, occupation, income, education, brushing, smoking, self-assessment of oral health, dental treatment utilization, number of admission, length of stay in psychiatric hospital, and type of anti-psychotic medication used. Decay Missing Filling Tooth index (DMF), Community Periodontal Index (CPI) and Probing depth (PD) were used for oral health examination. Data were analyzed with descriptive statistics and stepwise multiple regression analysis. Results showed that DMFT was 10.96 teeth per person and 34.1 % of them had periodontal disease. The factors that significantly related to DMFT (p-value<0.05) were age, number of admission, length of stay in the hospital and self-assessment  of oral health. Whereas age, smoking and 1st generation anti-psychotics medication were significantly related to periodontal pocket depth (p-value<0.05). Therefore, dental staff should work together with psychiatrists, nurses and caregivers to follow patients having the risk factors and provide appropriate dental treatment plan as well as preventive dental care. 


 

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
ธาตรีนรานนท์ ส. Factors affecting oral health status in Schizophrenia patients. Th Dent PH J [Internet]. 2017 Jun. 30 [cited 2024 May 17];22(1):58-6. Available from: https://he02.tci-thaijo.org/index.php/ThDPHJo/article/view/148608
Section
Original Article

References

1. Ruengtrakul S. Schizophrenia. In Textbook of psychiatry. 9th ed. Bangkok: Ruankaew Printing; 2005. p. 83-96. (in Thai)

2. Friedlander AH, Marder SR. The psychopathology, medical management and dental implication of schizophrenia. J Am Dent Assoc 2002;133(5): 603-10.

3.Prohmpradith S, Kaewmongkol S. The effect of clozapine and factors related periodontal status in patients with schizophrenia. J Ment Health Thai 2013; 21(3):160-70. (in Thai)

4. Friedlander AH, Liberman RP. Oral health care for the patient with schizophrenia. Spec Care Dent 1991;11(5):179-83.

5. Arnaiz A, Zumarraga M, Diez-Altuna I, Uriarte JJ, Moro J. Oral health and symptoms of schizophrenia. Psychiatry Res 2011;188(1):24-8.

6.Lotrakul M. Psychotropic drug. in Handbook of psychiatric medication. Bangkok: Thaihealthbook; 2007. p. 96-126. (in Thai)

7. Feinberg M. The problem of anticholinergic adverse effects in older patients. Drugs Aging; 1993;3(4):335-48.

8. Suttajit S. Schizophrenia: epidemiology and treatment. J Psychiatr Assoc Thailand 2009;54(Suppl 1):21s-37s. (in Thai)

9.Thomas A, Lavrenthia E, Karouzos C, Kontis C. Factors which influence the oral condition of schizophrenia patients. Spec Care Dent 1996;16(2):84-6.

10.Tani H, Uchida H, Suzuki T, Shimanuki H, Watanabe K. Dental conditions in inpatients with schizophrenia: A large-scale multi-site survey. BMC Oral health 2012;12:32. doi: 10.1186/1472-6831-12-32

11.Chu KY, Yang NP, Chou P, Chiu HJ, Chi LY. Factors associated with dental caries amonginstitutionalized residents with schizophrenia in Taiwan: a cross-sectional study. BMC Public Health 2010;10:482. Doi: 10.1186/1471-2458-10-482

12. Toomthong S. Oral health status of schizophrenic patients. Bangkok: Somdet chaopraya institute of psychiatry; 2005. (in Thai)

13. World Health Organization. International statistical classification of diseases and related health problems-10th revision. 5th ed. France: WHO; 2016.

14. Thorndike RM. Correlation procedures for research. Gardner Press Inc. New York; 1978.

15. Dental health Bureau. The 7th national oral health survey 2012 of Thailand. Bangkok: Department of health; 2013. (in Thai)

16. Wood DM, Mould MG, Ong SBY, Baker EH. “Pack year” smoking histories: what about patients who use loose tobacco? Tob Control 2005;14(2):141-2.

17. Wood SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003;64(6):663-7.

18. Santimalivorakul V, Pongchaidecha M. Effect of Trihexyphenidyl on memory function in schizophrenic patients. Thai bulletin of pharmaceutical sciences 2005; 2(1):1-11. (in Thai)

19. World Health Organization. Oral health survey, basic methods. 4th ed. Geneva: WHO; 1997.

20. Thatreenaranon S, Sarobol N, Toomthong S. The Impacts of oral health on daily life performance in schizophrenic patients. J Dent Assoc Thai 2006; 56(6):392-400. (in Thai)

21. Klinge V. Facilitating oral hygiene in patients with chronic schizophrenia. J Am Dent Assoc 1979; 99(4):644-5.

22. Bergstrom J. Cigarette smoking as risk factor in chronic periodontal disease. Community Dent Oral Epidemiol 1989; 17(5):245-7.

23. Moimaz SA, Zina LG, Saliba O, Garbin CA. Smoking and periodontal disease: clinical evidence for an association. Oral Health Prev Dent 2009;7(4):369-76.

24. Clark DB. Dental care for the patient with schizophrenia. Can J Dent Hygiene 2008; 42(1):17-24.